On-label and off-label drug use in the treatment of endometriosis

被引：40
|
作者：
Quaas, Alexander M. [1 ]
Weedin, Elizabeth A. [1 ]
Hansen, Karl R. [1 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Sect Reprod Endocrinol & Infertil, Oklahoma City, OK 73190 USA
来源：
FERTILITY AND STERILITY | 2015年 / 103卷 / 03期
关键词：
Endometriosis; off-label treatment; CHRONIC PELVIC PAIN; DOUBLE-BLIND; LEUPROLIDE ACETATE; SYMPTOMATIC ENDOMETRIOSIS; PENTOXIFYLLINE THERAPY; CONSERVATIVE SURGERY; LAPAROSCOPIC SURGERY; MEDICAL-MANAGEMENT; CONTRACEPTIVE PILL; VALPROIC ACID;
D O I：
10.1016/j.fertnstert.2015.01.006
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Endometriosis, characterized by the presence of endometrial glands and stroma in extrauterine locations, is a significant cause of pelvic pain and infertility, as well as a major health care burden. Although Food and Drug Administration (FDA)-approved treatments are available, the use of "off-label'' medications for endometriosis is widespread. In this review, we provide an overview of the current FDA-approved treatments, followed by a detailed review of the major "off-label'' treatments being used in the United States and worldwide, including efficacy, side effects, drug interactions, contraindications, and anomaly risks. ((c) 2015 by American Society for Reproductive Medicine.)
引用
收藏
页码：612 / 625
页数：14
相关论文
共 50 条
  • [1] On-label and off-label drug use in the treatment of female infertility
    Usadi, Rebecca S.
    Merriam, Kathryn S.
    [J]. FERTILITY AND STERILITY, 2015, 103 (03) : 583 - 594
  • [2] Introduction: On-label and off-label drug use in reproductive medicine
    Legro, Richard S.
    [J]. FERTILITY AND STERILITY, 2015, 103 (03) : 581 - 582
  • [3] On-label and off-label drugs used in the treatment of male infertility
    Chehab, Mahmoud
    Madala, Alosh
    Trussell, J. C.
    [J]. FERTILITY AND STERILITY, 2015, 103 (03) : 595 - 604
  • [4] Converting a drug from off-label to on-label use: Government subsidies and patient welfare
    Olsder, Wendy
    Martagan, Tugce
    Tang, Christopher S.
    [J]. DECISION SCIENCES, 2023, 54 (06) : 579 - 595
  • [5] Classification and characteristics of on-label and off-label apixaban use in Denmark and Sweden
    Vinter, Nicklas
    Linder, Marie
    Andersen, Morten
    Pedersen, Alma B.
    Madsen, Morten
    Schachterle, Stephen E.
    Ataher, Quazi
    Mo, Jingping
    Johnsen, Soren Paaske
    Ehrenstein, Vera
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (06) : 867 - 878
  • [6] Trends in On-label and Off-label Modafinil Use in a Nationally Representative Sample
    Penaloza, Renee A.
    Sarkar, Urmimala
    Claman, David M.
    Omachi, Theodore A.
    [J]. JAMA INTERNAL MEDICINE, 2013, 173 (08) : 704 - 706
  • [7] Drug rediscovery in gastroenterology: from off-label to on-label use of thioguanine in inflammatory bowel disease
    de Boer, Nanne K. H.
    Simsek, Melek
    Meijer, Berrie
    Neurath, Markus F.
    van Bodegraven, Ad
    Mulder, Chris J. J.
    [J]. GUT, 2023, 72 (10) : 1985 - 1991
  • [8] Prevalence of use of on-label and off-label psychotropics in the Greek pediatric population
    Pesiou, Stella
    Barcelo, Rafel
    Papazisis, Georgios
    Torres, Ferran
    Pontes, Caridad
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [9] Azithromycin and MGD: Is it possible to turn an off-label treatment into an on-label therapy?
    Sullivan, D. A.
    Kam, W. R.
    Ding, J.
    Liu, Y.
    [J]. ACTA OPHTHALMOLOGICA, 2014, 92
  • [10] Safety and efficacy of drug-eluting stents: On-label and off-label perspectives
    Weisz, Giora
    Stone, Gregg W.
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2008, 9 (01) : 46 - 61
12345